Sterile Endophthalmitis after Intravitreal Triamcinolone: A Possible Association with Uveitis

American Journal of Ophthalmology

Volumn 144, Issue 1, 2007, Pages

  Taban, Mehryar ^a   Singh, Rishi P ^a   Chung, Jeffrey Yau Huei ^a   Lowder, Careen Y ^a   Perez, Victor L ^a   Kaiser, Peter K ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MOXIFLOXACIN; TRIAMCINOLONE ACETONIDE;

ADULT; AGED; ARTICLE; BACTERIUM CULTURE; CASE STUDY; CLINICAL ARTICLE; CONTROLLED STUDY; COUNTING FINGER; DISEASE ASSOCIATION; ENDOPHTHALMITIS; EYE EXAMINATION; FEMALE; FOLLOW UP; FUNGUS CULTURE; HAND MOVEMENT; HUMAN; MALE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; UVEITIS; VISUAL ACUITY;

EID: 34250758724     PISSN: 00029394     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajo.2007.03.051     Document Type: Article

References (16)

1. Moshfeghi D.M., Kaiser P.K., Scott I.U., et al. Acute endophthalmitis following intravitreal triamcinolone acetonide injection. Am J Ophthalmol 136 (2003) 791-796
2. Antcliff R.J., Spalton D.J., Stanford M.R., Graham E.M., Ffytche T.J., and Marshall J. Intravitreal triamcinolone for uveitic cystoid macular edema: an Optical Coherence Tomography Study. Ophthalmology 108 (2001) 765-772
3. Greenberg P.B., Martidis A., Rogers A.H., Duker J.S., and Reichel E. Intravitreal triamcinolone acetonide for macular oedema due to central retinal vein occlusion. Br J Ophthalmol 86 (2002) 247-248
4. Martidis A., Duker J.S., Greenberg P.B., et al. Intravitreal triamcinolone for refractory diabetic macular edema. Ophthalmology 109 (2002) 920-927
5. Danis R.P., Ciulla T.A., Pratt L.M., and Anliker W. Intravitreal triamcinolone acetonide in exudative age-related macular degeneration. Retina 20 (2000) 244-250
6. Jonas J.B., Hayler J.K., Sofker A., and Panda-Jonas S. Intravitreal injection of crystalline cortisone as adjunctive treatment of proliferative diabetic retinopathy. Am J Ophthalmol 131 (2001) 468-471
7. Floman N., and Zor U. Mechanism of steroid action in ocular inflammation: inhibition of prostaglandin production. Invest Ophthalmol Vis Sci 16 (1977) 69-73
8. Bandi N., and Kompella U.B. Budesonide reduces vascular endothelial growth factor secretion and expression in airway (Calu-1) and alveolar (A549) epithelial cells. Eur J Pharmacol 425 (2001) 109-116
9. Wilson C.A., Berkowitz B.A., Sato Y., Ando N., Handa J.T., and de Juan Jr. E. Treatment with intravitreal steroid reduces blood-retinal barrier breakdown due to retinal photocoagulation. Arch Ophthalmol 110 (1992) 1155-1159
10. Ozkiris A., and Erkilic K. Complications of intravitreal injection of triamcinolone acetonide. Can J Ophthalmol 40 (2005) 63-68
11. Nelson M.L., Tennant M.T., Sivalingam A., Regillo C.D., Belmont J.B., and Martidis A. Infectious and presumed noninfectious endophthalmitis after intravitreal triamcinolone acetonide injection. Retina 23 (2003) 686-691
12. Westfall A.C., Osborn A., Kuhl D., Benz M.S., Mieler W.F., and Holz E.R. Acute endophthalmitis incidence: intravitreal triamcinolone. Arch Ophthalmol 123 (2005) 1075-1077
13. Moshfeghi D.M., Kaiser P.K., Bakri S.J., et al. Presumed sterile endophthalmitis following intravitreal triamcinolone acetonide injection. Ophthalmic Surg Lasers Imaging 36 (2005) 24-29
14. Wang L.C., and Yang C.M. Sterile endophthalmitis following intravitreal injection of triamcinolone acetonide. Ocul Immunol Inflamm 13 (2005) 295-300
15. Roth D.B., Chieh J., Spirn M.J., Green S.N., Yarian D.L., and Chaudhry N.A. Noninfectious endophthalmitis associated with intravitreal triamcinolone injection. Arch Ophthalmol 121 (2003) 1279-1282
16. Jonas J.B., Kreissig I., Spandau U.H., and Harder B. Infectious and noninfectious endophthalmitis after intravitreal high-dosage triamcinolone acetonide. Am J Ophthalmol 141 (2006) 579-580